Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.36 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.36 |
| ▸ | TOP1 | P11387 | 1/20 | 0.35 |
| ▸ | CTRC | Q99895 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CLK2 | P49760 | 1/20 | 0.35 |
| ▸ | HIPK1 | Q86Z02 | 1/20 | 0.35 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.35 |
| ▸ | HIPK2 | Q9H2X6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20108878 | 0.89 | PARP1 (0.40) | NOS1TOP1MEN1KMT2AALDH1A1 | |
| SCHEMBL20108872 | 0.87 | CCR1 (0.41) | EGLN1TOP1ALDH1A1KDM4EMAPT | |
| SCHEMBL20108846 | 0.85 | CYP1A1 (0.45) | NOS1CYP1A1CYP1B1CA12CYP11B1 | |
| SCHEMBL20108896 | 0.85 | NOS1 (0.39) | NOS1CYP1A1CYP1B1CA12CYP11B1 | |
| SCHEMBL20108906 | 0.85 | NOS1 (0.39) | NOS1CYP1A1CYP1B1CA12CYP11B1 | |
| SCHEMBL20108903 | 0.81 | CYP1A1 (0.37) | CYP1A1CYP1B1CYP11B1CYP11B2EGLN3 | |
| SCHEMBL20108851 | 0.78 | PARP1 (0.44) | TOP1MEN1KMT2AALDH1A1NPSR1 | |
| SCHEMBL20108877 | 0.77 | PARP1 (0.43) | CYP1A1CYP1B1CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL30414157 | 0.77 | CYP1A2 (0.55) | NOS1CYP1A1CYP1B1CA12CYP11B1 | |
| SCHEMBL16542814 | 0.77 | CYP1A2 (0.55) | NOS1CYP1A1CYP1B1CA12CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11155543-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | LG DISPLAY CO., LTD. (KR) | 2021-10-26 | — | — | US | disclosed |
| US-20180118742-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
| US-20180118742-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118742-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | OCIAD2, OCIAD1, PPOX | NOS1 1081/4885CYP1A1 984/4885CYP1B1 1088/4885 |
| US-11155543-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | OCIAD2, OCIAD1, PPOX | NOS1 1081/4885CYP1A1 984/4885CYP1B1 1088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.